Purchases and Sales Made in Q2 2023 in Nurix Therapeutics, Inc. (NRIX)
This table provides information about the institutional ownership of Nurix Therapeutics, Inc. (NRIX) during Q2 2023. The information is specifically focused on institutions that hold shares of Nurix Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-54.9K- 75.77% |
$478K - $729K
|
17.6K
$344K
|
|
|
Aug 10, 2023
Q2 2023
|
Citigroup Inc
|
SELL
|
- |
-66.1K- 58.48% |
$575K - $878K
|
47K
$919K
|
|
|
Aug 14, 2023
Q2 2023
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-109K- 69.93% |
$949K - $1.45M
|
46.9K
$918K
|
|
|
Aug 10, 2023
Q2 2023
|
Pictet Asset Management Sa
Geneva 73, V8 |
SELL
|
- |
-134K- 12.58% |
$1.17M - $1.78M
|
931K
$18.2M
|
|
|
Aug 14, 2023
Q2 2023
|
Nomura Holdings Inc
Tokyo, M0 |
SELL
|
- |
-159K- 54.98% |
$1.38M - $2.11M
|
130K
$2.54M
|
|
|
Aug 14, 2023
Q2 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-205K- 7.93% |
$1.78M - $2.72M
|
2.38M
$46.6M
|
|
|
Aug 14, 2023
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-218K- 40.33% |
$1.9M - $2.9M
|
323K
$6.31M
|
|
|
May 14, 2024
Q2 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-218K- 40.33% |
$1.9M - $2.9M
|
323K
$6.31M
|
|
|
Aug 14, 2023
Q2 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-310K- 13.85% |
$2.69M - $4.11M
|
1.93M
$37.7M
|